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Summary.-The use of perchloric acid and water for the extraction of CEA from
tumour and foetal tissues has beeninvestigated. In the case oftumour, lower recover-
ies of CEA were obtained from perchloric acid extracts than from aqueous extracts
of the same tissue. CEA has also been extracted with 3M KCI solution from in-
soluble perchloric acid residues oftumour homogenates and cancer patients' serum.
Whilst a large proportion of CEA activity recovered from tumour was associated
with the perchloric acid residue, the corresponding amounts from serum were very
small.
CEA elution volumes for each extract, obtained by assay of Sephadex G-200
column fractions, showed significant heterogeneity in molecular size. The purified
CEA pools also showed quantitative variations in the binding profiles on Con A-
Sepharose. It has been shown that perchloric acid modifies the carbohydrate in CEA,
thus altering its Con A-binding properties. Preliminary experiments with foetal
colon have demonstrated that, unlike colorectal CEA, a significant proportion of
foetal CEA was not bound to ConA. Comparative immunodiffusion showed immuno-
logical identity of CEA from the various extracts, although the purified aqueous
extract produced an additional precipitin reaction, indicating a second antigen which
is relatively unstable or less soluble in perchloric acid.
THE preliminary extraction of carcino-
embryonic antigen (CEA) with 1 OM
perchloric acid from liver metastases of
colonic tumours was described by Krupey
et al. (1972) and this method, with minor
modifications, has been largely adopted
by other workers as the initial stage in the
isolation of CEA for radioimmunoassay.
Exclusion chromatography on Sepharose
4B and Sephadex G-200 (Coligan et al.,
1972; Krupey et al., 1972) and concanava-
lin A affinity chromatography (Brattain
et al., 1975; Rogers, Searle and Bagshawe,
1976) have been used to purify the
product. CEA is a macromolecular glyco-
protein which has been shown to exhibit
heterogeneity in its electrophoretic mobil-
ity (Darcy, Turberville and James, 1973;
Rogers, Searle and Wass, 1975; Rule and
Goleski-Reilly, 1973a, b), isoelectric point
* To whom enquiries should be made.
(Coligan et al., 1973), molecular size
(Coligan et al., 1972) and in its ability to
bind to the lectin concanavalin A (Slayter
and Coligan, 1976).
Despite the widespread use ofperchloric
acidfortheisolationofCEA, studies onthe
possible effect of the acid on the carbo-
hydratestructureandheterogeneityof CEA
have not been widely reported. However,
a comparison of the use of whole plasma
and perchloric-acid-extracted plasma for
CEA radioimmunoassay has recently ap-
peared (Ashman, Ludbrook and Marshall,
1977). The present investigation provides
new comparative data on thefractionation
of aqueous and perchloric acid extracts of
CEA from tumour tissue, foetal colon and
serum, and is a further study in which the
chemistry and possible cancer-specificity
of various forms of CEA are examined.P. A. KEEP, B. A. LEAKE AND G. T. ROGERS
MATERIALS AND METHODS
Tissues
The primary colon tumours were obtained
surgically and processed immediately. All
metastatic tumour and normal colon tissues
were necropsy specimens obtained within
24 h of death and generally stored at -20°C
until used. The foetal colons were obtained
from 26 foetuses aged 15-20 weeks collected
over a period of 6 weeks.
Extraction procedure for tumour and normal
tissue
The scheme for extracting CEA from rectal,
colonic and bronchial tumour tissue and also
normal colon is given in Fig. 1. The tumour
(100-1500 g) was dissected from surrounding
normal tissue, minced and macerated in a
Townsen and Mercer top-drive macerator for
10 min in an equal volume of chilled water.
The homogenate was divided into two equal
portions: I and II (Fig. 1). Normal colon
tissue was dissected from fat, briefly washed
with water and cut into small pieces before
mincing and macerating.
Route I.-The aqueous homogenate was
centrifuged (30,000 g) for I h and the aqueous
extract and residue separated. An equal
volume of cold perchloric acid (2M) was
added to an aliquot of the aqueous extract
which was stirred for 5 min and recentrifuged
(30,000 g). The supernatant was dialysed
against tap water for 3 days and then
against distilled water, and concentrated by
ultrafiltration (Amicon PM 10) to 100-500
ml. The supernatant was designated Extract
A. The residues obtained from each centri-
fugation step were stirred overnight at 4°C
with 3M KCI (,200 ml/kg of original tissue),
centrifuged and the supernatant dialysed
against tap water and distilled water and
concentrated. These CEA extracts were
designated A-1 and A-2 respectively (see
Fig. 1). The CEA recovered in each extract
wvas estimated by routine radioimmunoassay.
Route II.-The other half of the aqueous
homogenate was treated directly with an
equal volume of 2M perchloric acid. After
stirring for 5 min the mixture was centrifuged
(30,000 g) for - h. The supernatant designated
B was dialysed and concentrated by ultra-
filtration. The residue was treated with 3M
KCI as described above and centrifuged and
the supernatant, designated B-1, was dialysed
and concentrated. The CEA content of each
extract was estimated.
Gelfiltration of crude extracts ofSpecimen 4
Aliquots of the crude extracts A, A-1, B
and B-1 containing 76, 1204, 126 and 104 mg
of protein and 7-1, 1-4, 6-8 and 2-7 mg of
CEA respectively were applied to a column of
Sepharose 6B (Pharmacia) (76 x 5 cm) pre-
viously equilibrated with sodium phosphate
buffer (01M, pH 4.5). The column was
eluted with the same buffer, at 43 ml/h and
Tissue homogenized
11
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FiG. 1. Scheme for extraction of CEA from tissues
3M KCI
A-l
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TABLE L.-Recoveries of CEA in Crude Tissue Extracts (,ug CEAlg wet tissue)
as Measured by Radioimmunoassay
HC104 HC104
Aqueous Prior cent. extract HC104 Specimen no. Tissue source extract A B B-
Ca colon (liver 20) 2-25 2-5 1-2
(Pool of 30 Ca colon (1°) 27-0 24-8 12-7
specimens)
Ca colon (2°) 1-7 1-3 1I {Ca colon (2°) 170 87
Ca colon (20) 44-9 64-3 8-E Ca rectum (2°) 0-16 0-18 0*10 0*3
Ca bronchus (2°) 0-18 0-14 0-08 012 Normal colon n.s. n.s. n.s. n. Foetal colon 0-14 6-8
n.s. CEA value not significant
- not assayed
4ppt.
*1
32
20o
E5
FRACTION NO.
FIG. 2.-Gel filtration of crude CEA extracts
A ( ), A-i(-I--), B (*) and B-1
0----) on Sepharose 6B.
the fractions (6-5 ml) monitored by their
absorbance at 280 mm and also assayed for
CEA (Fig. 2). The fractions with CEA
activity were pooled, concentrated by ultra-
filtration and dialysed against water. The
above CEA samples and the crude extract
A-2 were each further purified on a column of
Sephadex G-200 (Pharmacia) (75 X2-5 cm)
50 100 150 200 250 300
VOLUME OF ELUATE (ml )
FiG. 3.-Gel filtration of Sepharose 6B puri-
fied extracts. A ( ), A-I (- - -), B (...)
and B-1 (--- ) and crude extract A-2
(-0-0-) on Sephadex G-200.
350
equilibrated with the phosphate buffer. The
column was eluted with this buffer and 5-0 ml
fractions collected. The absorbance and CEA
activity for each fraction were recorded (Fig.
3) and the fractions containing CEA pooled,
dialysed and concentrated. The recoveries of
CEA from the Sepharose 6B and Sephadex
G-200 were in each case expressed as ug/g
wet tissue (Table II). The molecular weights
of the CEA peaks were estimated from the
elution volume on Sephadex G-200 by the
method ofWhitaker (1963) usingribonuclease
1
2
3
4
5
6
7
8
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TABLE II.-Recoveries of CEA (,tg/g wet tissue) in Fractions Obtained
from Liver Metastases of Colonic Cancer (Specimen No. 4)
Centrifugation prior to HC104 treatmnent
Purification
stage
Crude extract (1)
Crude extract (2)
Sepharose 6B
Sephadex G-200
Aqueous
extract
170-0
A-1
Aqueous
ppt.
(12-8)
15 -2
15-9
A, myoglobin, egg albumin, transferrin,
bovine y-globulin and thyroglobulin as
standards.
Concanavalin A-Sepharose affinity chromato-
graphy
This was carried out using a column
(29 x 10 cm) of concanavalin A-Sepharose
(Pharmacia) as previously described (Rogers
et al., 1974; Slayter and Coligan, 1976).
Briefly, this involved elution of fraction 1
with 0-1M sodium acetate buffer, pH 6,
containing IM NaCl, 10-3M CaC12, 10-3M
TABLE III.-Recovery of CEA from
Patients' Sera (CEA tug/l) from Various
Disease Groups in Perchloric-acid Ex-
tracts and Precipitates
Serum
pool
Non-colonic
Rectal-)
Rectal 20
RectalJ
Colonic
Colonic 20
Colonic J
Colonic 1°
Colonic
Gastric 2°
1C104
Extract B
122
117
140
154
360
257
280
16
6
78
HC104
Precipitate B-1
22
0-8
3 -4
3 5
9 -5
2 -2
3-4
n.s.
n.s.
n.s.
MgCl2 and 10-3M MnCl2. Fractions 2A, 2B
and 3 were eluted with sodium borate/
phosphate buffer (O1M, pH 6.0), 2% methyl
glucoside intheacetatebufferand 10% methyl
glucoside in the acetate buffer respectively.
Fraction 4 was obtained by soaking the
column contents overnight in 20% methyl
glucoside in the acetate buffer and then
eluting with the same solution. All fractions
were dialysed for at least 3 days to remove
salt and methyl glucoside, and then assayed
for CEA. The CEA recovered in each fraction
for extracts A, A-i, A-2, B and B-1 and the
A A-2
HC104 HC104
extract ppt.
87-0
44-9
28-7
27-7
Centrifugation after
HC104 treatment
B B-1
HC104 HC104
extract ppt.
0-9 64-3
35-4
0-4 34-5
8-5
9 -3
7 -4
aqueous extract (all derived from Specimen 4)
were expressed in percentages (Table IV).
The affinity column was constantly checked
for overloading, and between experiments it
was soaked overnight in 20% methyl gluco-
side and re-equilibrated with the acetate
buffer. All fractionations were carried out at
40C.
To determine the effect of perchloric acid
on the Con A fraction 2B obtained from the
aqueous extract, an aliquot of this was
treated with an equal volume of the 2M acid.
After stirring for 5 min the solution was
dialysed, concentrated and reapplied to the
Con A-Sepharose column. This was eluted
with the various buffers as described above
and the CEA recovered in each fraction
determined (Table IV).
Extraction offoetal colon tissue
Twenty-six foetal colons (45 g) were briefly
washed in water and cut into small pieces.
The tissue was then homogenized in 100 ml of
water for 10 min at 4°C, using an MSE top-
drive homogenizer fitted with an ice jacket.
The homogenate was centrifuged at 76,000 g
for 1 h and the aqueous extract and residue
separated. The residue was treated by
grinding with 50 ml of 3M KCI solution in a
mortar. After stirring overnight the mixture
was centrifuged and the KCI extract dialysed
against tap water and distilled water and
concentrated to 32 ml by Amicon (PM 10)
ultrafiltration. This extract was designated
A-I (see Fig. 1 and Table V). Half of the
aqueous extract (60 ml) was dialysed against
several changes of distilled water and con-
centrated to 35 ml; this was designated the
aqueous extract (Table V). The other half of
the aqueous extract was mixed with an equal
volume of 2M perchloric acid, stirred for
5 min and centrifuged at 76,000 g for 1 h.
The supernatant was dialysed against run-
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TABLE IV.-Fractionation on Con A-Sepharose of CEA Extracts A, A-1, A-2,
B and B-1, Purified on Sepharose 6B and Sephadex G-200
Extract
A
A-1
A-2
B
B-1
Aqueous
(crude extract)
Aqueous (HC1O4-
treated 2B)
CEA
applie(d
(Htg)
1200
790
190
3000
1590
521
1
2 2
4.7
3 9
3 5
3 1
6 1
2A
(0)
1-3
3 9
I.1
1*1
1 2
3 2
2B
(0)
23 2
30 7
17 6
32 0
27 8
33 5
3
(0)
14 6
19 9
14 8
20 9
19 5
24 5
4
(0)
20
24 8
32 8
28
33 3
30-1
69 12 6 0 7 41 2 26-7 32 6
Total CEA
recoveredl
/Lg (0)
735 3 61 3
663 2 84 0
133 3 70 2
2559 2 85 3
1350 3 84 9
508 0 97 5
78 0 100 0
TABLE V.-Recoveries of CEA from Foetal Colon (yg/g wet tissue)
in Crude Extracts and in Con A fractions
Aqueous
0
,ug/g recovery
0-14
7 0 70
0-2 2
1-8 18
1-0 10
10-0 100
Extract A
,ugl/g recovery
6 8
1*9
0 2
1*3
0 3
3-7
Extract A-1 from
aqueous ppt.
,Lg/g recovery
1*8
28 0 7 38
3 0 04 2
19 0- 15 8
4-4 0 03 1-6
54 0 9 50
Extract A-2 from
HC104 ppt.
,Lg/g recovery
02
005 25
n.s.
n.s.
n.s.
0(-05 25
ning tap water and against several changes of
distilled water to remove acid, and then
concentrated to 30 ml. This extract was
designated Extract A (Fig. 1 and Table V).
The perchloric acid residue was treated with
KCI solution as described above and concen-
trated to 20 ml; this extract was designated
A-2. The CEA content of each extract was
estimated byradioimmunoassay. Eachextract
was then fractionated on a column of Con
A-Sepharose and fractions 1, 2A, 2B and 3
collected as described above. The CEA
recovered in each fraction was estimated
after dialysis and concentration and expressed
as ,ug/g wet tissue.
Recovery of CEA from patient's sera
Sera from patients with colonic, rectal,
gastric and various non-colonic cancers known
to contain elevated levels of CEA were
collected and pooled as indicated in Table
III. In the case of patients with secondary
cancer of the colon or rectum, the sera were
pooled to contain at least 100 ,ug CEA/I but
in the case of sera from patients with primary
cancer this was not possible. Each serum pool
was mixed with an equal volume of 2M
perchloric acid and the stirring continued for
10 min. The mixture was centrifuged for 1 h
at 76,000 g and the supernatant and residue
separated. The residue was washed with 1M
perchloric acid. The supernatant and wash-
ings weredialysed againsttap water for 3days
and then against distilled water and concen-
trated to known volumes (-.10 ml) to give Extract-B. The residue above was washed
with distilled water and ground in a mortar
with 30 ml of 3M KCI and left stirring at 4°C
overnight. After centrifugation (76,000 g for
1 h) the supernatant was dialysed and con-
centrated to 10 ml to give Extract B-1. CEA
in Extracts B and B-1 was estimated and
expressed as ,ug/l of original serum pool
(Table III).
Radioimmunoassay of CEA
The CEA activity of all fractions after
dialysis wasdetermined on ourroutinedouble-
antibody assay using CEA-2B as label, a
conventional preparation of CEA (M-12) as
standard (Rogers, Searle and Bagshawe,
1976) and antiserum 227.
Antiserum 227.-This was prepared from
CEA-2B obtained by Con-A chromatography
Crude
Con A 1
2A
2B
3
Recovery
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of conventional CEA. Before inoculation the
CEA wvas further purified by immuno-
absorbent chromatography using a highly
specific anti-CEA serum. Antiserum 227 was
prepared in a rabbit by giving multiple-site
intradermal injections of CEA-2B distributed
in the flank. The rabbit received 20 jug of
CEA in 250 pu ofsaline emulsified with 250 IJ
of Freund's complete adjuvant. Similar
injections wvere given after 40 days and serum
collected every 10-14 days afterwards. Bleeds
1-6 wvere pooled and absorbed with freeze-
dried perchloric-acid extracts of normal
colon (40 mg/ml) and normal human plasma
(20 mg/ml). The antiserum was checked for
specificity by comparative immunodiffusion
using existing antisera. The completeness of
absorption wvas checked by immunodiffusion
against normal tissue extracts and by trial
radioimmunoassay performed concurrently
with our existing routine assay.
Immnunodiffusion studies
Double-diffusion reactions A-ere carried out
in 1950o agar containing 0.90o NaCl using
absorbed Antiserum 227. Thevariousfractions
were tested at the concentrations indicated
in the figures.
RESULTS AND DISCUSSION
Perchloric acid has been usedextensively
for the routine extraction of CEA from
tumour tissues and for the pretreatment of
plasma for indirect radioimmunoassay.
However, it has been shown that perchloric
acid can modify CEA (Rule and Goleski-
Reilly, 1973a;Carrico andlJsategui-Gomez,
1975). It is conceivable that perchloric
acid could cleave sialic acid residues in
CEA and modify other parts of the carbo-
hydrate structure leading to changes in its
properties.
Earlier unpublished studies from our
laboratory and studies reported by Carrico
and Usategui-Gomez (1975) had demon-
strated that the yield of CEA obtained
from colonic tumour tissue and measured
by radioimmunoassay was considerably
diminished by the perchloric acid treat-
ment, and this appears to be the case
with serum CEA also (Khoo, Hunt and
Mackay, 1973a; Khoo and Mackay, 1973;
Ashman et al., 1977). It has been demon-
strated further that CEA could be extrac-
ted from perchloric acid precipitates of
tumour tissue by stirring overnight with
3M KCI solution (Rogers, 1976) or HCI at
pH 3 0 (Dyce and Haverback, 1972). This
indicated that some of the CEA survived
irreversible denaturation by perchloric
acid and was precipitated, or more likely
altered in its capacity to bind to other
precipitated proteins in the tissue homo-
genate.
Studies on tumour tissue
To explore the above effects more fully
we have used various extraction proced-
ures as illustrated in Fig. 1. The recoveries
of CEA in the various extracts obtained
from colonic, rectal and bronchial tumours
are presented in Table I. About twice as
much CEA can be recovered in saline
extracts as from the conventional per-
chloric-acid extract B, thus confirming
our previous observations. However, when
the tissue homogenate was centrifuged and
perchloric acid added to the supernatant
(Extract A) the recovery of CEA was
better than that in Extract B, in all but
one case. In this the CEA content of the
tumour was unusually high (64 pLg/g). It
appears from these experiments that
perchloric-acid modifies some of the CEA
in such a way that it binds to the insoluble
part of the tissue homogenate.
The amount of CEA in perchloric acid
extracts of the tumours (Table I) ranged
from 01 to 87 jug/g tissue. The figures
obtained represent radioimmunoassay
values, and most of the results for
Extract B are within the range quoted
by Khoo et al. (1973b) for similar extracts.
The higher values (64.3 and 87 ,ug/g) were
obtained by extracting different samples
from the same specimen (No. 4) of a
large liver metastasis. The content of CEA
in this tissue was unusually high in our
experience but was typical of the CEA
content of the crude extracts obtained by
Coligan et al. (1972).
The detection of CEA in the KCI-
treated perchloric-acid precipitate B-1
(Table I) has confirmed our earlier un-
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published work in which the presence of
CEA in the precipitates was shown by
qualitativeimmunodiffusionreactions. The
assay values were surprising, however, as
they indicated in some cases that the CEA
content associated with the perchloric-
acid precipitate exceeded that in the
corresponding extract. Similarly, CEA
binding has been independently reported
to occur in perchloric-acid precipitates of
gastric tumours (Dyce and Haverback,
1972), and in this case no CEA was
detected in the supernatant by immuno-
diffusion. The presence of comparatively
large amounts of CEA in perchloric-acid
precipitates raises questions about the use
of perchloric acid for the routine prepara-
tion of CEA. The original CEA (Gold and
Freedman, 1965) was extracted using
phosphate-buffered saline, but more recent
methods employ either perchloric-acid
extractiondirectlyontumourhomogenates
(Coligan et al., 1972; Krupey et al., 1972)
or after an initial centrifugation step
(Plow and Edgington, 1975). It is there-
fore important to establish whether the
bound CEA differs chemically from non-
binding CEA or whether the effect of
perchloric acid merely diminishes the
yield.
Initial experiments using double diffu-
sion have shown that CEA could also be
extracted by treating the aqueous precipi-
tate A-1 with 3M KCI solution, indicating
that some molecules with CEA activity
are bound to the insoluble tissue debris
in the absence of perchloric acid. This
has been confirmed by radioimmunoassay
(Table II). Isoelectric focusing studies
have shown that perchloric acid denatures
or precipitates predominantly CEA mole-
cules with isoelectric points in the range
5-9 (Rule and Goleski-Reilly, 1973). These
molecules possess fewer sialic acid residues
than those which focus at lower pH value
(Coligan et al., 1973). A low sialic acid
content may therefore be a characteristic
ofthe binding ofCEAto precipitates in the
presence of perchloric acid. It remains to
be established if, in the absence of
perchloric acid, those CEA molecules with
a deficiency in sialic acid are the ones
which are extracted from the precipitate.
More recent work (Carrico and Usategui-
Gomez, 1975) has shown that perchloric
acid may also cause irreversible precipita-
tion of CEA.
CEA could not be detected by radio-
immunoassay in the soluble fractions, or
KCO extracts of precipitated fractions,
from several specimens of normal colon
tissue. Several workers (Martin etal., 1972;
Pusztaszeri and Mach, 1973; Rogers et al.,
1974) have indicated the presence of very
low amounts of CEA or CEA-like activity
in normal tissues, but the amounts are
often below the limit ofdetectability. Our
results at least make it unlikely that CEA
in normal colonic tissues could be masked
bybinding to either aqueous orperchloric-
acid precipitates. These experiments also
provide suitable controls showing that the
assay values obtained with the tumour
extracts are not due to non-specific inter-
actions of tissue proteins in the radio-
immunoassay.
Studies on pooled sera
The effect of perchloric acid on the
quantitation of CEA in patients' sera is
important in view of the different assay
methods in use. In those assays where
whole serum is used, the CEA values are
generally higher than in indirect assays
where the serum is extracted with per-
chloric acid (Khoo et al., 1973; Ashman et
al., 1977). Table II compares the distribu-
tion of CEA in the perchloric-acid extract
and precipitate for several pools of sera
from patients with cancer. Seven out of 10
experiments showed the presence of CEA
in the perchloric acid precipitate although,
in contrast to tumour tissue, the amount
was smaller than that in the supernatant.
Our results differ from those of Sorokin,
Kupchik and Zamcheck (1973) which
failed to showthe presence ofCEA activity
in serum precipitates. This discrepancy
may be due to the fact that these workers
used individual serum samples contain-
ing smaller amounts of CEA than our
pools of sera.
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The smaller amount of CEA obtained
from perchloric-acid precipitates of serum
than from perchloric acid precipitates of
colonic tumours may be due to prior
removal ofCEA, probably inanasialylated
form, from the circulation by the liver. If
this is so, any differences in cancer
specificity between perchloric-acid-soluble
CEA and precipitate CEA would not be
expected to show up in a comparison of
the direct and indirect assays. The lower
assay value obtained with the indirect
assay would then more probably be due to
irreversible precipitation of CEA, which
takes place on treatment with perchloric
acid (Carrico and Usategui-Gomez, 1975).
The recent comparative study by Ashman
et al. (1977) between a perchloric-acid
extracted ammonium-sulphate precipita-
tion assay and a whole-plasma double-
antibody assay is consistent with the
above concept. The study failed to show
any difference in cancer discriminatory
ability between the two assay systems.
Fractionation studies on extracts from
Specimen 4
CEA in each extract obtained from
Specimen 4 eluted as a single, fairly sharp
0.07
0.06
0.05
E
0.04
C-)
0.03 c
0
co
0.02 <
0.01
o.00
VOLUME OF ELUATE (ml)
FIG. 4.-Gel filtration of extracts A and B on
Sephadex G-200. Absorbance profiles A
(-O-O-), B (- - -); CEA profilesA ( ),
B(...).
band onSepharose 6B (Fig. 2). The elution
profiles on Sephadex G-200, however,
were not identical. Although a major peak
ofCEAactivitywasshownforeachextract,
the elution volumes varied, corresponding
to differences in molecular size (Fig. 3).
The CEA extracted from the perchloric-
acid precipitates A-2 and B-1 eluted as
sharp bands corresponding to molecular
sizes of 390,000 and 308,000 daltons
respectively. The CEA elution and the
absorbance profiles for the perchloric-acid-
soluble extracts A and B show that most
of the non-CEA protein in the lower
mol. wt range, present in Extract A, is
substantiallyreducedinExtractB (Fig. 4).
The CEA profiles of Extracts A and B
also show differences in molecular size.
Extract A displays a major peak of
activity with a molecular size of about
215,000 daltons and a shoulder ofactivity
of higher molecular size (e.-300,000
daltons). In contrast, Extract B shows the
major CEA component at an elution
volume corresponding to a molecular size
of 296,000 daltons, and a shoulder ofCEA
activity corresponding to a lower molecu-
lar size ('--200,000 daltons). These differ-
ences in the elution patterns of Extracts
A and B are difficult to interpret at the
molecular level. They may be due to
aggregation of CEA or binding of CEA to
tissue proteins. Centrifuging the tumour
homogenate before adding perchloric acid
has the effect of removing insoluble tissue
debris to which CEA would otherwise
bind. Thepresence ofCEA oflarge molecu-
lar size in tumour tissue has been noted
previously. The CEA preparation des-
cribed byKrupey et al. (1972) wasfraction-
ated on Sephadex G-200 into 2 peaks
with CEA activity, although the bulk of
the activity was present in the lower-mol.
wt fraction. Coligan et al. (1972) on the
other hand showed that the type of CEA
elution profile on Sephadex G-200 de-
pended on the tumour. Although a single
peak ofCEA activity with a sedimentation
constant of 6-8 S was more typical, some
tumours produced CEA which chromato-
graphed with a double peakshowing that a
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large proportion of the CEA had a higher
mol. wt. The extent to which hetero-
geneity in molecular size in CEA is an
artefact resulting from the extraction
procedure is unknown, although in this
context it is interesting to note that CEA
with a molecular size of370,000 daltons has
been detected in both perchloric-acid-
extracted serum and in whole serum from
patients with cancer (Pletsch and Golden-
berg, 1974).
The recovery of CEA at each stage of
purification is given in Table II. In the 2
perchloric-acid extracts A and B the
recoveries after G-200 chromatography
were 62 and 54% respectively, typical of
recoveries obtained by Coligan et al. (I972).
The large amount of CEA lost at the
Sepharose stage is difficult to account for,
but this must be to some extent due to
spreading of the CEA band on the column
and to selection of the prominent CEA
peak for further purification.
The results of concanavalin A-affinity
chromatography of the partially purified
extracts of CEA, obtained by Sepharose
and Sephadex chromatography, are pre-
sented in Table IV. Five fractions were
collected as described earlier, with most
of the CEA appearing in fractions 2B, 3
and 4, and very small recoveries in the
unbound peak and Peak 2A. This is in
agreement with our previous studies
(Rogers et al., 1976) and also those of
Pritchard and Todd (1976) who found the
unbound material to contain predomi-
nantly non-CEA mucopolysaccharides. In
the present work we have eluted tightly
bound material from the column after
soaking overnight in 20% methyl
glucoside, as suggested by Slayter and
Coligan (1976), thereby improving our
total recoveries of CEA.
The recoveries of CEA in the Con A
peaks of Extract B and the corresponding
extract obtained from the precipitate B-1,
are almost identical (Table IV). This
indicates that the distribution and affini-
ties of the Con A-binding sites are not
significantly altered in CEA obtained
from the perchloric-acid residue. If this
were the case, quite different elution
patterns for perchloric-acid-soluble and
precipitated CEA would be expected. In
view of this, and the known chemistry of
Con A binding, together with the fact that
Con A binds to the intermediate carbo-
hydrate chains of CEA (Rogers, 1976), it
may be inferred that differences in soluble
CEA and CEA from perchloric-acid preci-
pitates may be restricted to carbohydrate
residues on the periphery of CEA. Our
result, although providing only indirect
evidence, appears to be compatible with
the possible role sialic acid might play in
the susceptibility of CEA to precipitation
in the presence of perchloric acid. The
different elution patterns on Con A
obtained with Extracts A and A-I,
compared to those obtained with the
Extracts B and B-1 just described, may
be correlated with the differences in
molecular size described earlier, but they
are difficult to interpret in detail. It may
be concluded, however, that the differ-
ences result from an overall effect of the
different extraction procedures on the
chemical structure of the carbohydrate
chains in CEA. It appears that, to some
extent, heterogeneity of CEA, as demon-
strated by Con A affinity chromatography,
is dependent on chemical changes in the
carbohydrate caused by the action of
perchloric acid. Whether carbohydrate
heterogeneity is also due to aggregation
of CEA or binding to other glycoproteins
is unknown.
The recoveries of CEA in the Con A
fractions obtained from the aqueous
extract of Specimen 4 (Table IV) show
similarities with the extracts discussed
above. However, by treating the Con A
fraction 2B obtained from the aqueous
extract, with perchloric acid, its Con A
binding is altered (Table IV). After
treatment and rechromatography on Con
A-Sepharose almost 60% of CEA-2B was
eluted in Peaks 1, 3 and 4. Although not
surprising, this is an important result,
since it demonstrates directly that per-
chloric acid alters the carbohydrate struc-
ture in CEA obtained by aqueous extrac-
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tion, and suggests that most preparations
of CEA in current use are chemically
different from native CEA. It will be
necessary to determine whether perchloric
acid causes similar chemical alterations in
circulating CEA.
Immunological studies on purified extractts
of CEA
Immunological identity between CEA
from the various extracts after purification
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FIG. 6. Comparative bindiing curves of CEA
B (0) and B-1 (A) demonstrating the
inhibition of binding of 125I-CEA (assay
standar(d) to antiserumn 227.
has been demonstrated by immuno-
diffusion using Antiserum 227 (Fig. 5).
Comparative binding studies, demonstrat-
ing the ability ofCEA B and B-I to inhibit
the binding of labelled CEA and Anti-
serum 227, produced superimposable
curves (Fig. 6), providing further evidence
for immunological identity between per-
chloric-acid-soluble CEA and CEA from
the perchloric-acid precipitate. Fig. 5 also
shows the immunodiffusion results for
CEA-2B purified by Con A affinity
chromatography from various extracts,
including an aqueous extract of tumour.
Again a line of identity was obtained
showing the presence of the conventional
CEA determinant. Although more difficult
to see in the stained gel (Fig. 5) original
observation of the immunodiffusion plate
clearly showed the presence of an addi-
tional precipitin line in the case of the
purified aqueous extract, which was partly
hidden and much weaker in the perchloric-
acid extracts. This suggests the presence
of 2 distinct antigens, the CEA antigen
and a second antigen which appears to
be relatively unstable, or less soluble, in
perchloric acid. The presence of 2
distinct antigens in aqueous extracts of
tumour has also previously been reported
by Carrico and Usategui-Gomez (1975).
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The second antigen may be similar to our
previously described B-antigen which was
also detected in purified CEA preparations
after Con A fractionation, and by using
conventional anti-CEA antisera (Rogers
et al., 1974, 1975). Our previous difficulties
experienced in isolating this antigen from
perchloric-acid extracts of tumour may be
due to its instability or low solubility in
acid, and we are now attempting the
isolation of the B-antigen from aqueous
extracts in order to compare it with the
second antigen described above.
It is clear from the present study that
perchloric acid alters the chemical struc-
ture of CEA. This manifests itself by
alteration of the Con A binding sites of
CEA, causing different fractionation pat-
terns with Extracts A and B, and also
with the aqueous extract before and after
perchloric acid treatment. The effect of
perchloric acid is also shown by modifica-
tion of some forms of CEA so that they
bind to insoluble tissue precipitates and
are no longer soluble. It also appears that
perchloric acid may affect different species
of CEA in different ways. Some species
appear to remain immunologically intact
and soluble in perchloric acid, others are
modified and bind to tissue homogenates
but remain immunologically intact, where-
as others again are irreversibly denatured,
causing diminished overall yields of CEA.
The implications of the present study
on our recently published work (Rogers
et al., 1977) on the disease specificity of
Con A fractions of perchloric-acid-treated
serum CEA, are difficult to ascertain until
the chemical effects of perchloric acid on
serum CEA have been established. Never-
theless our initial work suggested that
heterogeneity ofthe carbohydrate appears
to give rise to CEA molecules which vary in
specificity for local and metastatic cancer,
and that this specificity appeared not to
be impaired by the action of perchloric
acid.
Extraction of CEA from foetal colon
The recoveries of CEA in the crude
extracts A, A-1 and A-2 of foetal colon
are shown in Table V together with per-
centage recoveries obtained from fractions
produced by Con A affinity chromato-
graphy. In contrast to colorectal tumour
CEA, there appeared to be a marked
increase in the CEA-like activity of the
aqueous extract when this was treated
with 2M perchloric acid. This suggests
that perchloric acid is capable of dis-
sociating possible complexes and exposing
CEA-like activity which may be masked
in the aqueous extract. Whether the
increase in the assay value is due to CEA
or an unrelated protein which inhibits or
interferes in our CEA radioimmunoassay
is unknown, and must wait further
experimentation. However, non-specific
interference in the assay by high salt
concentration or low pH can be ruled out
because of the extensive dialysis carried
out on the fractions before assay.
In contrast to colorectal tumour CEA, a
significant proportion of foetal CEA-like
activity was not bound by Con A. The
CEA which did bind in each case appeared
predominantly in Fraction 2B, with very
little in Fraction 3. This binding is similar
to that found when sera of patients with
local cancer were chromatographed on
Con A-Sepharose (Rogers et al., 1977).
Comparison between the recoveries for the
Con A fractions of aqueous and perchloric-
acid-treated foetal CEA also show that
part of the CEA in the unbound fraction
and Fraction 3, on treatment with
perchloric acid, is either denatured or
irreversibly bound to the ConA-Sepharose.
Undoubtedly, further work is required to
substantiate these results, but the striking
differences described in these preliminary
experiments between colorectal CEA and
foetal CEA areinteresting and may suggest
important differences in the structure of
the carbohydrate chains.
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